|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.34 USD | -0.51% |
|
-4.23% | +40.80% |
| 06-29 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell 2500 Growth Benchmark | CI |
Quotes 5-day view: Celldex Therapeutics, Inc.
Delayed Quote Nasdaq| 2026-07-08 | 2026-07-09 | 2026-07-10 | 2026-07-13 | 2026-07-14 | |
|---|---|---|---|---|---|
| Last | US$38.96 | US$38.98 | US$39.11 | US$38.53 | US$38.24 |
| Volume | 1,618,302 | 612,506 | 694,010 | 660,189 | 344,177 |
| Change | -2.43% | +0.05% | +0.33% | -1.48% | -0.51% |
| Opening | US$39.48 | US$39.30 | US$38.90 | US$38.61 | US$38.70 |
| High | US$40.19 | US$39.59 | US$39.19 | US$38.66 | US$39.22 |
| Low | US$38.68 | US$38.56 | US$37.81 | US$37.53 | US$38.24 |
Performance
| 1 day | -0.51% | ||
| 1 week | -4.23% | ||
| Current month | +2.77% | ||
| 1 month | +19.05% | ||
| 3 months | +14.73% | ||
| 6 months | +45.18% | ||
| Current year | +40.80% | ||
| 1 year | +63.70% | ||
| 3 years | +2.55% | ||
| 5 years | -12.51% | ||
| 10 years | -43.10% |
Volumes
marketsDaily volume
344,177
Estimated daily volume
386,252
Avg. Volume 20 sessions
1,463,571
Daily volume ratio
0.26
Avg. Volume 20 sessions USD
56,105,994.29
Record volume 1
61,347,760
Record volume 2
23,143,410
Record volume 3
22,069,560
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
3,024,299,534
Net sales (USD)
1,545,000
Number of employees
198
Sales / Employee (USD)
7,803
Free-Float
99.73 %
Free-Float capitalization (USD)
3,016,109,482
Average Daily Capital Traded
1.86%
Indicators
Moving average 5 days
39.1
Moving average 20 days
35.26
Moving average 50 days
32.89
Moving average 100 days
31.88
Price spread / (MMA5)
+2.00%
Price spread / (MMA20)
-8.01%
Price spread / (MMA50)
-14.20%
Price spread / (MMA100)
-16.83%
STIM
RSI 9 days
72.53
RSI 14 days
70.51
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.51% | -4.23% | +63.70% | +2.55% | 3.02B | ||
| -1.05% | +1.39% | +3.15% | +6.98% | 50.61B | ||
| +0.42% | -3.22% | +380.38% | +591.37% | 39.11B | ||
| +0.43% | +0.01% | +30.05% | -5.81% | 34.64B | ||
| +0.74% | -0.83% | +21.52% | +56.06% | 33.79B | ||
| -1.31% | -1.76% | +1.59% | +27.01% | 26.89B | ||
| +0.64% | -0.11% | - | - | 16.47B | ||
| +1.41% | -1.72% | +67.59% | +120.75% | 15.14B | ||
| -0.72% | +0.12% | +14.69% | +16.95% | 13.85B | ||
| +1.26% | -0.20% | +12.62% | -31.62% | 12.72B | ||
| Average | +0.13% | -1.24% | +66.14% | +87.14% | 24.62B | |
| Weighted average by Cap. | +0.03% | -1.11% | +80.19% | +119.98% |
Historical Quotes: Celldex Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
1046a2526f75f5854f3ef722b55f6743._zQY29QD3_4ERSVgz1tTjxgXwowW9ciwNw9MYaDmdjI.l2VR9rFBr8k1MEsutS83_31EiL8vrKniQHopUuGCHmqHYmqukzKsk1IpFQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 15:17:09 | 38.24 | 100 | 262,868 |
| 15:17:09 | 38.27 | 100 | 262,768 |
| 15:17:09 | 38.27 | 100 | 262,668 |
| 15:17:07 | 38.28 | 100 | 262,568 |
| 15:17:06 | 38.28 | 100 | 262,468 |
| 15:17:06 | 38.28 | 100 | 262,368 |
| 15:17:06 | 38.28 | 100 | 262,268 |
| 15:17:06 | 38.29 | 100 | 262,168 |
| 15:16:44 | 38.30 | 100 | 262,068 |
| 15:16:28 | 38.30 | 114 | 261,968 |
Course Extremes
| 1 week | 37.52 | 40.18 | |
| 1 month | 31.05 | 40.3 | |
| Current year | 22.33 | 40.3 | |
| 1 year | 19.72 | 40.3 | |
| 3 years | 14.4 | 53.18 | |
| 5 years | 14.4 | 57.2 | |
| 10 years | 1.5 | 75.3 |
Monthly variations
Annual variations
| 2026 | +41.86% | ||
| 2025 | +7.48% | ||
| 2024 | -36.28% | ||
| 2023 | -11.02% | ||
| 2022 | +15.35% | ||
| 2021 | +120.55% | ||
| 2020 | +685.65% | ||
| 2019 | -24.88% | ||
| 2018 | -93.03% | ||
| 2017 | -19.77% | ||
| 2016 | -77.42% | ||
| 2015 | -14.08% | ||
| 2014 | -24.62% | ||
| 2013 | +260.80% | ||
| 2012 | +158.08% | ||
| 2011 | -36.89% | ||
| 2010 | -11.78% | ||
| 2009 | -41.04% | ||
| 2008 | +3.80% |
- Stock Market
- Stocks
- CLDX Stock
- Quotes Celldex Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















